Dalhoff A, Ullmann U
Abteilung für Medizinische Mikrobiologie, Klinikum der Christian-Albrechts-Universität, Kiel, FRG.
Eur J Clin Microbiol Infect Dis. 1990 Jul;9(7):479-87. doi: 10.1007/BF01964287.
On the basis of a review of published literature it is demonstrated that pharmacokinetic parameters of antibacterial agents correlate well with therapeutic efficacy in animal models, provided pharmacodynamic parameters are taken into account. The time that serum levels exceed the MIC is the most significant parameter determining efficacy of beta-lactams, whereas the efficacy of aminoglycosides is dependent on serum concentrations and the area under the curve. The efficacy of quinolones tends to be correlated to the doses administered or drug levels achieved. However, specific pharmacodynamic properties contribute significantly to the therapeutic efficacy of a few quinolones only whereas other quinolones lack these specific pharmacodynamic attributes. Thus, the correlation of pharmacokinetic parameters with therapeutic efficacy provides important basic concepts for the design of preclinical and clinical studies in the course of which additional pharmacodynamic properties will become apparent.
基于对已发表文献的综述表明,在考虑药效学参数的情况下,抗菌药物的药代动力学参数与动物模型中的治疗效果具有良好的相关性。血清水平超过最低抑菌浓度(MIC)的时间是决定β-内酰胺类药物疗效的最重要参数,而氨基糖苷类药物的疗效则取决于血清浓度和曲线下面积。喹诺酮类药物的疗效往往与给药剂量或达到的药物水平相关。然而,特定的药效学特性仅对少数喹诺酮类药物的治疗效果有显著贡献,而其他喹诺酮类药物缺乏这些特定的药效学属性。因此,药代动力学参数与治疗效果的相关性为临床前和临床研究的设计提供了重要的基本概念,在此过程中,其他药效学特性将变得明显。